Daniel P. Walsh Named President and Chief Executive Officer of Winthrop-University Hospital
Winthrop Receives "Accreditation with Commendation" from the Joint Commission on the Accreditation of Healthcare Organizations
Osteoporosis Study Underway: Participants Sought
Urogynecology: Female Incontinence is a Quality of Life Issue
New Chief of Pediatric Orthopaedics is Appointed
For Long Islanders Whose Children Don't Have Health Insurance
April Courses at Winthrop-University Hospital's Community Training Center
Nassau County's First ApligrafTM Skin Graft is Performed at Winthrop
Winthrop's Dr. Ibrahim Implants the "Reveal" Device
Pulmonary Rehabilitation Program at Winthrop: Dedicated to an Improved Quality of Life for Patients
Research: A Critical Element in Winthrop's Approach to Care for the Pulmonary Patient
New Medication for Rheumatoid Arthritis
Asthma Study - Phase IV Trial of the Serevent "Diskus"®
Pediatric Pulmonary Specialists at Winthrop Focus on Patients' Individual Needs ...Including Education of Parents and Caregivers
Winthrop's Sleep Disorders Center... The Only Accredited Sleep Disorders Facility in Nassau County
Skin Cancer - A Year Round Concern
Women's Cancer Specialist Joins Winthrop's Department of Obstetrics/Gynecology as Director of Gynecologic Oncology
SECOND ANNUAL CANCER SURVIVORS DAY
Looking for someone who understands a woman's special needs?
The 14th Annual Winthrop-University Hospital Golf Tournament
Back to Publications
osing consciousness, even for a short time, can be very frightening - especially if you cannot fathom the cause. Fainting - technically known as syncope - accounts for three per cent of all Emergency Department visits, and one to six per cent of all hospital admissions. A full ten per cent of the population will experience an episode of syncope at least once in their lifetime.
Bassiema Ibrahim, MD, a cardiac electrophysiologist and Director of Telemetry with Winthrop's Division of Cardiology, is the first electrophysiologist in New York State to implant a Reveal® device in a patient - an implantable Holter monitor loop recorder that records the heart's rhythm during an episode of syncope. The Reveal® device is about the size of a human thumb - eight cubic centimeters, weighing 17 grams.
In conjunction with the 53-year-old male patient's cardiologist, Michael Sassower, MD, Voluntary Attending with Winthrop's Division of Cardiology, Dr. Ibrahim performed the 20 minute procedure, using local anesthesia. Only a one inch incision in the patient's upper left chest was required. The patient had been experiencing multiple episodes of syncope, followed by related hospitalizations, for the past year.
Once implanted, the Reveal® continuously records up to 42 minutes of the patient's heart rhythms - before, during, and after the episode of syncope.
Dr. Ibrahim correctly points to the difficulty of accurately diagnosing syncope and identifying its causes, largely because of syncope's transiency. The patient often regains consciousness by the time a physician intervenes, but the episodes frequently recur.
Bassiema Ibrahim, MD, Director of Telemetry at Winthrop-University Hospital
Once implanted, the Reveal®
continuously records up to 42
minutes of the patient's heart rhythms - before, during, and
after the episode of syncope. When the patient regains consciousness, he can self-activate the device.
The stored EKG rhythms can be retrieved non-invasively and
analyzed to "reveal" whether the syncope was caused by an
abnormality in the heart rhythm. Once a diagnosis has been made, the Reveal® device may be safely removed by the electrophysiologist.
Patients suffering syncope caused by a cardiac abnormality are reported to experience a one year mortality rate in 20-30 per cent of all cases. As cardiac arrhythmias can cause sudden death, their identification and treatment are critical to survival.
Fainting could be caused by abnormalities in various organ systems, including the cardiovascular, neurological, and metabolic systems. Tracing the causes of fainting is crucial to providing appropriate care. Syncope episodes also hold major prognostic implications, and there are various tests available to aid in diagnosis. "However, the root cause of the episode remains unexplained in about 30% of patients, even after exhausting all non-invasive and invasive tools," Dr. Ibrahim concedes. This unresolved situation can lead to repeated symptoms, re-admissions to the Hospital, and further testing. The Reveal® device will help to lead the way to an accurate diagnosis in many cases.
Those who have been troubled with unexplained episodes of syncope, who seek an accurate diagnosis, are urged to contact Dr. Ibrahim at 516/663-2085.